US Patent 7105166 Soluble CTLA4 mutant molecules and uses thereof
Patent 7105166 was granted and assigned to Bristol-Myers Squibb on September, 2006 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7105166 Soluble CTLA4 mutant molecules and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
